- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06386159
Clinical Application of Comprehensive Intervention for PED Based on Neuroregulatory Mechanism
June 28, 2024 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
Clinical Application of Comprehensive Intervention Scheme for Post-extubation Dysphagia Based on Neuroregulatory Mechanism
This study aims to establish a practical comprehensive intervention program for dysphagia after extubation in adult ICU patients based on the best evidence of its assessment and intervention, through expert panel discussion and Delphi method.
In addition, combining the preliminary experimental results of vagus nerve stimulation applied to PED patients, we further develop a comprehensive intervention program for dysphagia after extubation based on neural regulation mechanism.
Finally, the implementation effect of this PED comprehensive intervention program based on neural regulation mechanism will be verified through clinical application.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiuqin Feng
- Phone Number: 13757119151
- Email: fengxiuqin@zju.edu.cn
Study Locations
-
-
-
Jinhua, China
- Recruiting
- Jinhua Municipal Central Hospital
-
Contact:
- Haiping Xu
- Phone Number: 13506587812
- Email: 240931013@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients who met the diagnostic criteria of PED were changed to SSA score ≥24
- aged from 18 to 90 years old;
- oral or nasotracheal intubation for ≥48 hours;
- Clear mind
- Glasgow score ≥13 points, with good cooperation ability;
- There was no contraindication to oral feeding after extubation
Exclusion Criteria:
- Other diseases that affect swallowing function (such as stroke, Parkinson's disease, head and neck deformity, radiotherapy after head and neck cancer, burn with inhalation injury, esophageal cancer, chronic obstructive pulmonary disease, etc.);
- history of reflux and aspiration;
- tracheotomy;
- isolation treatment due to respiratory infectious diseases;
- the presence of implantable electronic devices (e.g., pacemakers, cochlear implants);
- Traumatic vagus recurrent laryngeal nerve injury, history of vagus nerve surgery, or vagus nerve injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
During routine medical care and nursing, the responsible nurse provides daily oral care and delivers health education to patients and their caregivers regarding diet and swallowing safety.
Within 8 hours after the removal of the endotracheal tube, the Standardized Swallowing Assessment (SSA) is used to screen for swallowing function.
Patients are guided in food selection based on the severity of their swallowing difficulties and personal preferences, and are supplemented with enteral or parenteral nutrition or prescribed specific diets as directed by their doctor.
|
|
|
Active Comparator: Comprehensive Intervention Group
On the basis of the control group, a comprehensive intervention plan determined through Delphi expert consultation is implemented for PED patients.
This plan includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management.
The duration and frequency of the exercises are tailored to the patient's actual condition.
|
Comprehensive intervention includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management.
Transcutaneous electrical stimulation of the vagus nerve at the lateral neck was performed by rehabilitation therapists.
The cervical vagus nerve accompanies the carotid artery and is located at the groove between the trachea and the sternocleidomastoid muscle, which can be located by touching the carotid pulse.
The two electrodes were pasted along the path of the cervical vagus nerve.
|
|
Experimental: Comprehensive Intervention Combined with Vagus Nerve Stimulation Group
On the basis of the control group, a comprehensive intervention is implemented in combination with vagus nerve electrical stimulation.
|
Comprehensive intervention includes multidisciplinary collaboration, screening and assessment, oral sensory training, oral motor training, respiratory training, and feeding management.
Transcutaneous electrical stimulation of the vagus nerve at the lateral neck was performed by rehabilitation therapists.
The cervical vagus nerve accompanies the carotid artery and is located at the groove between the trachea and the sternocleidomastoid muscle, which can be located by touching the carotid pulse.
The two electrodes were pasted along the path of the cervical vagus nerve.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
functional oral intake scale(FOIS)
Time Frame: up to 90 days
|
FOIS consists of seven levels: ① Score 1, unable to eat orally at all; ② Score 2, dependent on tube feeding, minimum attempt to eat food or liquid; ③ Score 3, dependent on tube feeding, taking single texture food or liquid orally; ④ Score 4, completely oral intake of single texture food; ⑤ score 5: fully oral intake of a variety of food textures, but with special preparation or compensation; ⑥6 points, completely oral feeding without special preparation, but with special food restriction; ⑦7 points, complete oral feeding without restriction, the higher the score, the better the swallowing function of the patient.
In this study, a FOIS score of 6-7 was defined as full oral feeding
|
up to 90 days
|
|
standardized Swallowing Assessment(SSA)
Time Frame: up to 90 days
|
The first part is the clinical examination.The second part involves observing the patient's ability to swallow 5 mL of water, repeated three times.
If there are no abnormalities detected in the above examinations, the amount of water for swallowing is then increased to 60 mL.
To obtain the total score, the scores from all three parts are summed up.
|
up to 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of total oral feeding after the intervention
Time Frame: up to 90 days
|
After the intervention, the patient's score on the Functional Oral Intake Scale (FOIS) was between 6 and 7, indicating that the patient has recovered the ability to eat orally.
|
up to 90 days
|
|
Duration of Enteral Nutrition Tube Indwelling
Time Frame: up to 90 days
|
The duration of the nasogastric tube or nasointestinal tube indwelling in the patient
|
up to 90 days
|
|
Rate of Re-intubation after Endotracheal Intubation
Time Frame: up to 90 days
|
The rate of re-intubation during the intervention period after extubation in patients who have undergone endotracheal intubation
|
up to 90 days
|
|
Incidence of aspiration within one week after extubation
Time Frame: up to 90 days
|
Incidence of aspiration within one week after extubation
|
up to 90 days
|
|
The incidence of aspiration pneumonia within one week after extubation
Time Frame: up to 90 days
|
The incidence of aspiration pneumonia within one week after extubation
|
up to 90 days
|
|
Inflammation-related indicators: serum C-reactive protein (CRP)
Time Frame: up to 90 days
|
Monitoring of patients' inflammatory marker
|
up to 90 days
|
|
Inflammation-related indicators: serum interleukin-6 (IL-6)
Time Frame: up to 90 days
|
Monitoring of patients' inflammatory marker
|
up to 90 days
|
|
Inflammation-related indicators: serum procalcitonin, acetylcholine (ACh)
Time Frame: up to 90 days
|
Monitoring of patients' inflammatory markers
|
up to 90 days
|
|
Inflammation-related indicators: high mobility group box-1 protein (HMGB1)
Time Frame: up to 90 days
|
Monitoring of patients' inflammatory marker
|
up to 90 days
|
|
Days of ICU hospitalization
Time Frame: up to 90 days
|
Days of ICU hospitalization
|
up to 90 days
|
|
Total days of hospitalization
Time Frame: up to 90 days
|
Total days of hospitalization
|
up to 90 days
|
|
In-hospital survival rate
Time Frame: up to 90 days
|
The number of patients who survive during hospitalization
|
up to 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2024
Primary Completion (Estimated)
April 30, 2025
Study Completion (Estimated)
July 30, 2025
Study Registration Dates
First Submitted
April 24, 2024
First Submitted That Met QC Criteria
April 25, 2024
First Posted (Actual)
April 26, 2024
Study Record Updates
Last Update Posted (Actual)
July 1, 2024
Last Update Submitted That Met QC Criteria
June 28, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-1178
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-extubation Dysphagia
-
Wuhan UniversityActive, not recruitingPost-extubation DysphagiaChina
-
Radboud University Medical CenterTerminated
-
Atlantic Health SystemRecruitingPost Extubation DysphagiaUnited States
-
Assiut UniversityNot yet recruitingPediatric Post Extubation Dysphagia
-
University Hospital, AntwerpRecruitingPost Extubation StridorBelgium
-
Fayoum UniversityActive, not recruitingUpper Airway Edema | Post Extubation Stridor | Upper Airway UltrasonographyEgypt
-
First Teaching Hospital of Tianjin University of...Recruiting
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Chimei Medical CenterUnknownPost-Extubation StridorTaiwan
-
Société Française d'Anesthésie et de RéanimationCompletedUnplanned Extubation | Self ExtubationFrance
Clinical Trials on Comprehensive Intervention or Comprehensive Intervention Combined with Electrical vagus nerve stimulation
-
Icahn School of Medicine at Mount SinaiCompletedPostural Tachycardia Syndrome | Post-COVID-19 Syndrome | DysautonomiaUnited States
-
University of FloridaCompleted
-
Affiliated Hospital of Nantong UniversityCompleted
-
Uppsala County Council, SwedenUppsala University; Region Gävleborg; Västmanland County Council, Sweden; Uppsala...CompletedMedication ReviewSweden
-
University of MinnesotaParkinson's FoundationRecruitingParkinson's Disease (PD) | PARKINSON DISEASE (Disorder)United States
-
Shanghai Institute of Acupuncture, Moxibustion...Shanghai Pudong Hospital of Traditional Chinese MedicineCompletedUrinary Incontinence Following Surgical ProcedureChina
-
Jing HanNot yet recruitingDepressive Disorder | Acute Coronary Syndrome (ACS) | Percutaneous Coronary Intervention (PCI) | Heart Rate Variability (HRV) | Depressive Disorder (Per DSM-V Criteria, Mild-to-moderate) | Postoperative Psychological Distress | Inflammatory Factors | Randomized Controlled Trial (RCT)China
-
Mukoviszidose Institut gGmbHHannover Medical School; Goethe University; Federal Ministry of Health, Germany; Wuerzburg University Hospital and other collaboratorsCompleted
-
Bahçeşehir UniversityCompleted
-
University of MinnesotaCompletedTourette Syndrome | Tic Disorders | Tics | Tourette Syndrome in Children | Tourette Syndrome in Adolescence | Tic Disorder, Childhood | Tic, MotorUnited States